better by nature

Productivity. Health. Sustainability.

better productivity

Improved productivity. Naturally.

Drive yield per acre through improved pest management, growth stimulation and input utilizations.

better nutrition

We are what we eat.

Providing produce with reduce chemical residue and improved nutritional values

better future

Good practices. Sustainable planet.

Environmentally friendly ag-solutions – preserving our planet resources

our mission

Improve food quality, sustainability and agriculture productivity, through microbiome based,
AI-driven ag-biologicals products

Better by nature

Better food for consumers with improved quality and health attributes. Better agriculture for a sustainable enviroment.

Nature is the ultimate resource – we partner with the untapped potential of the microbiome.

our products

Lavie Bio’s ag-biological products under development are based on the naturally occurring microbial population living close to or within the plant.

Bio-Stimulants

Enhancing plant performance

Bio-Pesticides

Protecting plants from pests

Product Pipeline

Program

Product focus

Target market*

Potential expansion*

Discovery

Pre-dev.

Dev. Stage 1

Dev. Stage 2

Pre-commercialization

Commercial

Bio-Stimulants

Seed treatment, Spring Wheat North America
25M ACRES wheat North America
500M ACRES
COMMERCIAL

LAV228
Bio-stimulants 2

Seed treatment Soy North America
80M ACRES soy US
210M ACRES
PRE-DEV

Bio-Pesticides

LAV311, 312
Fruit rots

Foliar Fruits & Veg Europe North America
<$200M grapes chemicals usage
+$800M Additional Fruits & Veg
PRE-COMMERCIALIZATION

LAV321
Downey mildew

Foliar Fruits & Veg Europe North America
<$350M grapes chemicals usage
+$150M Additional Fruits & Veg
DEV. STAGE 1

LAV332, LAV335
Seedling disease
(Pythium)

Seed Treatment, Corn, soy, F&V North America Europe
<$500M
<$200M
PRE-DEV

LAV443, LAV442
Bio-Insecticides

Seed Treatment, Corn, foliar soy North America Europe
<$1.5B existing traits and chemicals market
<$500M
PRE-DEV

our technology

Biology Driven Design platform (BDD)

The BDD platform facilitates and accelerates the design and development of microbiome-based products through the decoding of complex microbiome/host interactions and the identification of the key genetic elements (functions) governing these interactions. This decoding, which enables amplification of positive or elimination of negative, and/or the retrieval of lost interactions, is powered by big data and artificial intelligence, provides the basis for products design.

 

Amplify positive interactions

Eliminate negative interactions

Retrieve lost interactions

Powered by

  • Evogene’s MicroBoost AI tech- engine

  • Taxon technology platform

System Modeling

Analysis

Design

Validation

System Modeling

Lavie Bio harnesses Microbiome, host and environmental OMIC interconnected BIG DATA hub that is core in its ability to Discover, Optimize and Develop products.

With more than 5 PETABYTES of integrated and interconnected data Lavie Bio can model the complex microbiome-host interaction as a basis for Analysis and Design.

The interconnected data hub is evolving constantly based on validation results and other data sets.

Analysis

Lavie Bio’s proprietary algorithms, leveraging advanced informatic technologies, enable it to use the genomic prism as its language.

Through the multi – layer OMIC data we understand the role of key genetic elements for product design.

Design

Microbes are functional units. Compiling the right set of functionality of the product and optimizing their performance are key for success

We utilize our in-silico design technology for discovery and optimization of microbial products.

Based on the genetic prism understanding we prioritize and improve key functions as well as develop fermentation protocols and formulation technologies – in order to drive efficacy, stability and commercial viability.

Validation

The biological screening & validation platform is an inherent part of Lavie Bio’s technology platform.

The platform’s ‘in-planta’ component translates ‘in-silico’ predictions into results which are then fed back into the platform’s in-silico component.

This feedback loop, based on carefully tailored data, continuously improves Lavie Bio’s prediction capabilities.